Discovering the role of somatostatin in Alzheimer’s disease pathogenesis

How a Neurotransmitter Could Be The Key To Controling Alzheimer’s Toxicity

Summary: A study reveals that copper and somatostatin affect the pathology of Alzheimer’s disease.

Source: KAIST

Alzheimer’s is the most common form of neurodegenerative diseases, with nearly 50 millions dementia patients in the world. The main symptom of Alzheimer’s disease is an impairment in general cognitive abilities. This includes the ability to speak and remember.

With an aging population, and a life expectancy that is ever increasing, it’s important to find a cure. The cause of this terrible disease has not yet been defined.


How a Neurotransmitter May Be the Key in Controlling Alzheimer’s Toxicity​

Leave a Reply

Your email address will not be published. Required fields are marked *